Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
CMA fines drugmakers £260m for 10,000% price hike
Europe
The UK’s Competition and Markets Authority has imposed fines of £260 million on drug companies for raising the price of life-saving hydrocortisone tablets by 10,000%.   15 July 2021
Novartis accused of owing $47m in IP royalties
Americas
Novartis should pay a Daiichi Sankyo subsidiary, Plexxikon, $47 million in overdue IP royalties, according to an argument presented before a federal court in California this week.   15 July 2021
Sacha Baron Cohen sues cannabis company for copyright infringement
Plant Varieties
Actor and comedian Sacha Baron Cohen is suing a US medical cannabis company for its use of his controversial Borat character on a billboard advertisement without his authorisation.   13 July 2021
Medtech
The English High Court has cleared Roche of patent infringement claims over its line of insulin pumps but shot down the pharma giant’s attempt to invalidate the plaintiff’s patent.   13 July 2021
Generics
An executive order by President Joe Biden has targeted anti-competitive practices in the US drugs market, including a ban of pay-for-delay agreements.   13 July 2021
Generics
US prosecutors have charged the founders of Taiwanese biosimilar manufacturer JHL Biotech with stealing Genentech trade secrets.   8 July 2021
Americas
Roche unit Spark Therapeutics is pursuing a “misguided” lawsuit that contravenes its stated mission to combat systemic racism, according to gene therapy developer Bluebird Bio.   8 July 2021
Big Pharma
Poland’s largest pharmaceutical company has asked the federal court to let it pursue arbitration in a Swiss court for a trade secrets dispute between India’s Rubicon Research and North Carolina biotech firm Kartha Pharmaceuticals.   8 July 2021
Medtech
Masimo wants to bar Apple from selling the Apple Watch Series 6, alleging the mobile manufacturer infringed five of its blood pressure monitoring patents.   6 July 2021
Generics
Teva Pharmaceuticals has filed lawsuits in New Jersey against two Indian generics manufacturers to stop them from developing a generic version of its Huntington’s disease treatment.   6 July 2021